Serum urate outcomes of treat-to-target urate lowering treatment: results of a nationwide cohort study from 1997 to the COVID-19 pandemic using data from the Clinical Practice Research Datalink.

Abhishek, Abhishek; Cipolletta, Edoardo; Nakafero, Georgina; Avery, Anthony J; Mamas, Mamas; Tata, Laila J

Abhishek, Abhishek; Cipolletta, Edoardo; Nakafero, Georgina; Avery, Anthony J; Mamas, Mamas; Tata, Laila J.

Abhishek A; Academic Rheumatology, University of Nottingham, Nottingham, UK abhishek.abhishek@nottingham.ac.uk.
Cipolletta E; Academic Rheumatology, University of Nottingham, Nottingham, UK.
Nakafero G; Clinica Reumatologica, Universita Politecnica delle Marche, Jesi, Ancona, Italy.
Avery AJ; Academic Rheumatology, University of Nottingham, Nottingham, UK.
Mamas M; Population and Lifespan Sciences, University of Nottingham, Nottingham, UK.
Tata LJ; Keele Cardiovascular Research Group, Keele University, Stoke on Trent, UK.

Ann Rheum Dis ; 81(12): 1768-1769, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-1909697

Subject(s)

COVID-19; Gout; Humans; Uric Acid; Cohort Studies; Pandemics; Gout Suppressants/therapeutic use; Gout/drug therapy; Allopurinol/therapeutic use

Keywords

Gout; Quality Indicators, Health Care; Therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Gout Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article Affiliation country: Ard-2022-222668

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google